CHICAGO, Oct. 10 /PRNewswire-FirstCall/ — Allscripts Healthcare
Solutions, Inc. (“Allscripts”) (Nasdaq: MDRX), the leading provider of
clinical software, connectivity and information solutions that physicians use
to improve healthcare, announced today that the per share amount of the
previously announced special cash dividend is $5.23 per share of common stock.
The payment of the special cash dividend, which is expected to occur on
October 17, 2008, is contingent upon the closing of the transactions
contemplated by the Agreement and Plan of Merger dated as of March 17, 2008
entered into by Allscripts, which, subject to the satisfaction of remaining
closing conditions, is expected to occur today. As previously announced, the
record date for the special cash dividend was October 9, 2008. Holders of
Allscripts common stock who sell their shares through October 10, 2008 also
will be selling their right to receive the special cash dividend. The date on
which Allscripts common stock will first trade without the right to the
special cash dividend is expected to be October 13, 2008.
(Logo: http://www.newscom.com/cgi-bin/prnh/20061005/ALLSCRIPTSLOGO-b)
As of the close of business on the record date for the special cash
dividend, holders of approximately $54.6 million aggregate principal amount of
Allscripts’ 3.50% Convertible Senior Debentures elected to convert into shares
of Allscripts common stock.
About Allscripts
Allscripts is the leading provider of clinical software, connectivity and
information solutions that physicians use to improve healthcare. The company’s
unique solutions inform, connect and transform healthcare, delivering improved
care at lower cost. More than 40,000 physicians and thousands of other
healthcare professionals in clinics, hospitals and extended care facilities
nationwide utilize Allscripts to automate everyday tasks such as writing
prescriptions, documenting patient care, managing billing and scheduling, and
safely discharging patients, as well as to connect with key information and
stakeholders in the healthcare system. To learn more, visit Allscripts at
https://www.allscripts.com
Forward-Looking Statements
This communication contains forward-looking statements. Those forward-
looking statements include all statements other than those made solely with
respect to historical fact. Forward-looking statements may be identified by
words such as “believes,” “expects,” “anticipates,” “estimates,” “projects,”
“intends,” “should,” “seeks,” “future,” continue,” or the negative of such
terms, or other comparable terminology. In addition, statements made in this
communication about anticipated financial results, future operational
improvements and results or conditions and approvals are also forward-looking
statements. Such forward-looking statements are subject to numerous risks,
uncertainties, assumptions and other factors that are difficult to predict and
that could cause actual results to vary materially from those expressed in or
indicated by them. Such factors may include, but are not limited to: (1) the
occurrence of any event, development, change or other circumstances that could
give rise to the termination of the merger agreement; (2) the outcome of any
legal proceedings that have been or may be instituted against Allscripts,
Misys or MHS and others; (3) the inability to complete the proposed
transaction due to the failure of any party to satisfy other conditions to
completion of the proposed transaction; (4) risks that the proposed
transaction disrupts current plans and operations and potential difficulties
in employee retention as a result of the merger; (5) the ability to recognize
the benefits of the merger; (6) legislative, regulatory and economic
developments; and (7) other factors described in filings with the Securities
and Exchange Commission. Many of the factors that will determine the outcome
of the subject matter of this communication are beyond Allscripts’ ability to
control or predict. Allscripts can give no assurance that any of the
transactions related to the merger will be completed or that the conditions to
the transactions will be satisfied. Allscripts undertakes no obligation to
revise or update any forward-looking statement, or to make any other forward-
looking statements, whether as a result of new information, future events or
otherwise. Allscripts is not responsible for updating the information
contained in this communication beyond the published date, or for changes made
to this communication by wire services or Internet service providers.
SOURCE Allscripts Healthcare Solutions, Inc.